Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary
- This topic has 0 replies, 1 voice, and was last updated 3 years, 1 month ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer
https://pubmed.ncbi.nlm.nih.gov/33645367/
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.